dc.creator | Humphreys, Derek | |
dc.creator | Schlesinger, Liana | |
dc.creator | Lopez, Marcelo | |
dc.creator | Araya, A. Verönica | |
dc.date.accessioned | 2018-12-20T15:09:58Z | |
dc.date.available | 2018-12-20T15:09:58Z | |
dc.date.created | 2018-12-20T15:09:58Z | |
dc.date.issued | 2006 | |
dc.identifier | Endocrine, Volumen 30, Issue 3, 2018, Pages 371-376 | |
dc.identifier | 1355008X | |
dc.identifier | 10.1007/s12020-006-0016-1 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/158089 | |
dc.description.abstract | The present study was designed to determine whether an association exists between HPA activity and cytokine production in major depression (MD). In 9 patients with MD and 11 control subjects of both sexes, all drug-free, activity of the HPA axis was evaluated by circadian rhythm of plasma cortisol, 24-h free urinary cortisol, an overnight 1 mg dexamethasone suppression test, and an oCRF stimulation test. Spontaneous and LPS-stimulated production of IL-1β, IL-6, and TNFα by peripheral blood mononuclear cells were also determined. We found a significantly elevated spontaneous production of IL-6 in patients with MD (3541.2 ± 726.8 vs 380.4 ± 77.5 pg/mL in controls, p < 0.05), while LPS-stimulated production was significantly lower in patients than in control subjects (19,867.7 ± 3649.2 vs 33,142.2 ± 15,47.2 pg/mL, p < 0.05). The adrenocorticotropic hormone response to oCRF, evaluated as the area under the curve (AUCACTH) was significantly lower in patients than in control subjects (p = 0. | |
dc.language | en | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Endocrine | |
dc.subject | HPA axis | |
dc.subject | IL-6 | |
dc.subject | LPS | |
dc.subject | Major depressive disorders | |
dc.title | Interleukin-6 production and deregulation of the hypothalamic-pituitary- adrenal axis in patients with major depressive disorders | |
dc.type | Artículos de revistas | |